首頁 > 市場調查報告書 > 材料/化學品

市場調查報告書

商品編碼

2084715

克拉維酸鉀市場：按劑型、應用、最終用戶、通路和地區分類。

Clavulanate Potassium Market, By Formulation Type, By Application, By End User, By Distribution Channel, By Geography

出版日期: 2026年06月04日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，克拉維酸鉀市場規模將達到 17.426 億美元，到 2033 年將達到 25.748 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.7%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	17.426億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.70%	2033年市場規模預測：	25.748億美元

克拉維酸鉀是與阿莫西林等BETA-內醯胺類抗生素聯合使用的關鍵成分，使其成為全球製藥業的領先產品。該藥物透過抑制細菌釋放的BETA-內醯胺酶來擴大抗菌頻譜，從而阻止其與阿莫西林的相互作用。它常用於多種聯合療法中，治療呼吸道、泌尿道、皮膚和軟組織、耳部以及各種牙科感染疾病。

該市場涵蓋了以克拉維酸鉀為主要成分的藥品研發、生產和銷售，涉及製藥企業、學名藥企業和生物技術公司。市場成長的促進因素包括細菌感染疾病日益普遍、醫療保健成本不斷上漲、抗生素抗藥性問題日益嚴重以及新興經濟體醫療保健服務可近性的提高。此外，藥品產能的擴張、學名藥供應量的增加以及全球醫院、診所、零售藥局和網路零售通路需求的成長，也進一步推動了市場發展。

市場動態

全球克拉維酸鉀市場的主要促進因素包括細菌感染疾病的日益普遍、全球抗生素抗藥性威脅的日益加劇，以及BETA-內醯胺酶抑制劑在增強常用抗生素對抗各種抗藥性菌株的療效方面的重要性日益凸顯。此外，醫療保健領域支出的增加、開發中國家醫療服務可及性的改善、對抗生素使用的更深入了解以及全球人口老化加劇也是推動市場成長的因素。

然而，嚴格的監管合規和耗時的核准程序阻礙了市場成長。品牌藥專利到期、抗生素副作用日益嚴重、抗藥性菌的出現，都持續限制市場成長。儘管如此，新劑型的推出和新型生產技術的出現，正在創造豐富的商機。對聯合治療的需求不斷成長，以及產品在獸藥領域應用範圍的擴大，正在推動這一成長趨勢。此外，開發中國家醫療基礎設施的改善以及製藥公司之間日益增多的業務合作，也為市場成長開闢了新的前景。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球克拉維酸鉀市場的主要公司概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份《全球克拉維酸鉀市場報告》旨在為該行業的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球克拉維酸鉀市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

GSK plc
Sandoz Group AG
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma Limited
Lupin Limited
CSPC Pharmaceutical Group Limited
North China Pharmaceutical Group Corporation
United Laboratories International Holdings Limited
ACS Dobfar SpA

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9579

Clavulanate Potassium Market is estimated to be valued at USD 1,742.6 Mn in 2026 and is expected to reach USD 2,574.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,742.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.70%	2033 Value Projection:	USD 2,574.8 Mn

Clavulanate potassium is a prominent product within the global pharmaceutical industry as it is a crucial component used in combination with beta-lactam antibiotics, such as amoxicillin. This medication works by inhibiting beta-lactamase enzyme released from bacteria and preventing its effects on amoxicillin, thus expanding the antibacterial coverage. It is prescribed as part of various combined medications to treat infections of the respiratory tract, urinary tract, skin and soft tissue, ear, and various dental infections.

The market consists of pharmaceutical manufacturers, generic drug makers and biotech companies which is involved in the development, manufacturing, and sale of clavulanate potassium-based drugs. The increase in prevalence of bacterial infection, rise in healthcare expenditure, growing concern over the development of antimicrobial resistance and the increase in availability of healthcare services in emerging economies are driving the growth of this market. In addition, growing pharmaceutical production capacity, increased availability of generic medications, and rising demand by hospital, clinic, retail pharmacy and the internet distribution channel in worldwide is reinforcing the market trends.

Market Dynamics

The global clavulanate potassium market is primarily driven by the increasing number of bacterial infections, the rising threat of antibiotic resistance globally, and the growing importance of beta-lactamase inhibitors in rendering commonly used antibiotics more effective against various drug-resistant bacterial strains. Increasing expenditure in healthcare sector, access to healthcare services in developing nations, and better understanding about use of antibiotics, rising number of old age population across the world is also driving the market.

However, market growth is impeded by stringent regulatory compliances and time-consuming approval procedures. Patent expiry for branded drugs and the growing menace of antibiotic-induced adverse effects and resistance development continue to impede market growth. Nevertheless, ample opportunities are being generated through the launch of new formulations and the advent of new manufacturing techniques. The growth trend is boosted with growing demand for combination therapies and rising application of the products in veterinary medicine. Moreover, the development of better healthcare infrastructure in underdeveloped economies along with business alliances between pharmaceutical firms further opens up new vistas for growth.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global clavulanate potassium market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc, Sandoz Group AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, CSPC Pharmaceutical Group Limited, North China Pharmaceutical Group Corporation, United Laboratories International Holdings Limited, and ACS Dobfar S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global clavulanate potassium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clavulanate potassium market

Market Segmentation

Formulation Type Insights (Revenue, USD Mn, 2021 - 2033)
Oral Formulations
Injectable Formulations
Application Insights (Revenue, USD Mn, 2021 - 2033)
Respiratory Tract Infections
Urinary Tract Infections
Skin and Soft Tissue Infections
Other Bacterial Infections
End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals
Clinics
Homecare Settings
Others
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
GSK plc
Sandoz Group AG
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma Limited
Lupin Limited
CSPC Pharmaceutical Group Limited
North China Pharmaceutical Group Corporation
United Laboratories International Holdings Limited
ACS Dobfar S.p.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Clavulanate Potassium Market, By Formulation Type
- Global Clavulanate Potassium Market, By Application
- Global Clavulanate Potassium Market, By End User
- Global Clavulanate Potassium Market, By Distribution Channel
- Global Clavulanate Potassium Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Clavulanate Potassium Market, By Formulation Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Injectable Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Clavulanate Potassium Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Respiratory Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Skin and Soft Tissue Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Other Bacterial Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Clavulanate Potassium Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Clavulanate Potassium Market, By Distribution Channel, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Clavulanate Potassium Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

GSK plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sandoz Group AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aurobindo Pharma Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSPC Pharmaceutical Group Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
North China Pharmaceutical Group Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
United Laboratories International Holdings Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ACS Dobfar S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies